Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Income Statement
Earnings Waterfall
Mirum Pharmaceuticals Inc
Revenue
|
186.4m
USD
|
Cost of Revenue
|
-47m
USD
|
Gross Profit
|
139.3m
USD
|
Operating Expenses
|
-248.5m
USD
|
Operating Income
|
-109.2m
USD
|
Other Expenses
|
-54.3m
USD
|
Net Income
|
-163.4m
USD
|
Income Statement
Mirum Pharmaceuticals Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
11
N/A
|
16
+45%
|
19
+20%
|
32
+67%
|
39
+20%
|
52
+36%
|
77
+47%
|
96
+24%
|
116
+21%
|
145
+25%
|
186
+29%
|
|
Gross Profit | ||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(4)
|
(7)
|
(10)
|
(12)
|
(15)
|
(19)
|
(27)
|
(47)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
17
N/A
|
12
-32%
|
27
+128%
|
43
+59%
|
65
+52%
|
81
+25%
|
97
+19%
|
118
+22%
|
139
+18%
|
|
Operating Income | ||||||||||||||||||
Operating Expenses |
(55)
|
(71)
|
(80)
|
(86)
|
(104)
|
(130)
|
(155)
|
(181)
|
(191)
|
(78)
|
(76)
|
(77)
|
(196)
|
(206)
|
(215)
|
(229)
|
(248)
|
|
Selling, General & Administrative |
(12)
|
(15)
|
(18)
|
(20)
|
(23)
|
(27)
|
(36)
|
(47)
|
(59)
|
(69)
|
(76)
|
(82)
|
(89)
|
(100)
|
(112)
|
(126)
|
(146)
|
|
Research & Development |
(43)
|
(55)
|
(62)
|
(66)
|
(82)
|
(102)
|
(119)
|
(133)
|
(131)
|
(117)
|
(108)
|
(104)
|
(107)
|
(106)
|
(103)
|
(103)
|
(103)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
108
|
108
|
108
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(55)
N/A
|
(71)
-29%
|
(80)
-14%
|
(86)
-7%
|
(104)
-21%
|
(130)
-25%
|
(144)
-11%
|
(165)
-15%
|
(173)
-5%
|
(51)
+71%
|
(45)
+12%
|
(35)
+22%
|
(131)
-279%
|
(126)
+4%
|
(118)
+6%
|
(111)
+7%
|
(109)
+1%
|
|
Pre-Tax Income | ||||||||||||||||||
Interest Income Expense |
2
|
3
|
3
|
2
|
1
|
(2)
|
(9)
|
(13)
|
(18)
|
(19)
|
(16)
|
(15)
|
(11)
|
(9)
|
(6)
|
(3)
|
(1)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
108
|
0
|
0
|
0
|
0
|
0
|
(49)
|
(49)
|
(49)
|
|
Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
1
|
0
|
(0)
|
(2)
|
(0)
|
(3)
|
|
Pre-Tax Income |
(53)
N/A
|
(68)
-29%
|
(78)
-14%
|
(84)
-8%
|
(103)
-23%
|
(132)
-28%
|
(153)
-16%
|
(179)
-17%
|
(84)
+53%
|
(70)
+17%
|
(60)
+15%
|
(48)
+19%
|
(142)
-195%
|
(135)
+5%
|
(176)
-30%
|
(163)
+7%
|
(162)
+1%
|
|
Net Income | ||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
7
|
7
|
6
|
6
|
(1)
|
(1)
|
(1)
|
|
Income from Continuing Operations |
(53)
|
(68)
|
(78)
|
(84)
|
(103)
|
(132)
|
(153)
|
(179)
|
(84)
|
(70)
|
(53)
|
(42)
|
(136)
|
(129)
|
(176)
|
(164)
|
(163)
|
|
Net Income (Common) |
(53)
N/A
|
(68)
-29%
|
(78)
-14%
|
(84)
-8%
|
(103)
-23%
|
(132)
-28%
|
(153)
-16%
|
(179)
-17%
|
(84)
+53%
|
(70)
+17%
|
(53)
+24%
|
(42)
+21%
|
(136)
-225%
|
(129)
+5%
|
(176)
-36%
|
(164)
+7%
|
(163)
+0%
|
|
EPS (Diluted) |
-2.28
N/A
|
-2.74
-20%
|
-3.1
-13%
|
-3.34
-8%
|
-4.09
-22%
|
-4.4
-8%
|
-5.05
-15%
|
-5.88
-16%
|
-2.77
+53%
|
-2.23
+19%
|
-1.65
+26%
|
-1.19
+28%
|
-4.01
-237%
|
-3.42
+15%
|
-4.62
-35%
|
-3.99
+14%
|
-4
0%
|